S&P 500   4,567.79 (+0.50%)
DOW   35,754.95 (+0.22%)
QQQ   377.70 (+0.96%)
AAPL   148.84 (+0.10%)
MSFT   308.57 (-0.19%)
FB   325.12 (+0.16%)
GOOGL   2,747.76 (-0.13%)
TSLA   994.66 (+9.34%)
AMZN   3,322.00 (-0.41%)
NVDA   232.86 (+2.46%)
BABA   175.96 (-0.98%)
NIO   41.02 (+5.50%)
CGC   13.33 (-0.37%)
GE   105.73 (+1.61%)
AMD   122.89 (+2.56%)
MU   69.09 (+2.34%)
T   25.46 (-0.12%)
F   15.97 (-1.90%)
ACB   7.13 (+0.85%)
DIS   172.16 (+1.62%)
PFE   42.94 (-0.51%)
BA   212.38 (-0.28%)
AMC   37.07 (+1.28%)
S&P 500   4,567.79 (+0.50%)
DOW   35,754.95 (+0.22%)
QQQ   377.70 (+0.96%)
AAPL   148.84 (+0.10%)
MSFT   308.57 (-0.19%)
FB   325.12 (+0.16%)
GOOGL   2,747.76 (-0.13%)
TSLA   994.66 (+9.34%)
AMZN   3,322.00 (-0.41%)
NVDA   232.86 (+2.46%)
BABA   175.96 (-0.98%)
NIO   41.02 (+5.50%)
CGC   13.33 (-0.37%)
GE   105.73 (+1.61%)
AMD   122.89 (+2.56%)
MU   69.09 (+2.34%)
T   25.46 (-0.12%)
F   15.97 (-1.90%)
ACB   7.13 (+0.85%)
DIS   172.16 (+1.62%)
PFE   42.94 (-0.51%)
BA   212.38 (-0.28%)
AMC   37.07 (+1.28%)
S&P 500   4,567.79 (+0.50%)
DOW   35,754.95 (+0.22%)
QQQ   377.70 (+0.96%)
AAPL   148.84 (+0.10%)
MSFT   308.57 (-0.19%)
FB   325.12 (+0.16%)
GOOGL   2,747.76 (-0.13%)
TSLA   994.66 (+9.34%)
AMZN   3,322.00 (-0.41%)
NVDA   232.86 (+2.46%)
BABA   175.96 (-0.98%)
NIO   41.02 (+5.50%)
CGC   13.33 (-0.37%)
GE   105.73 (+1.61%)
AMD   122.89 (+2.56%)
MU   69.09 (+2.34%)
T   25.46 (-0.12%)
F   15.97 (-1.90%)
ACB   7.13 (+0.85%)
DIS   172.16 (+1.62%)
PFE   42.94 (-0.51%)
BA   212.38 (-0.28%)
AMC   37.07 (+1.28%)
S&P 500   4,567.79 (+0.50%)
DOW   35,754.95 (+0.22%)
QQQ   377.70 (+0.96%)
AAPL   148.84 (+0.10%)
MSFT   308.57 (-0.19%)
FB   325.12 (+0.16%)
GOOGL   2,747.76 (-0.13%)
TSLA   994.66 (+9.34%)
AMZN   3,322.00 (-0.41%)
NVDA   232.86 (+2.46%)
BABA   175.96 (-0.98%)
NIO   41.02 (+5.50%)
CGC   13.33 (-0.37%)
GE   105.73 (+1.61%)
AMD   122.89 (+2.56%)
MU   69.09 (+2.34%)
T   25.46 (-0.12%)
F   15.97 (-1.90%)
ACB   7.13 (+0.85%)
DIS   172.16 (+1.62%)
PFE   42.94 (-0.51%)
BA   212.38 (-0.28%)
AMC   37.07 (+1.28%)
NASDAQ:MDGL

Madrigal Pharmaceuticals SEC Filings & 10K Form

$78.10
-0.21 (-0.27 %)
(As of 10/25/2021 01:59 PM ET)
Add
Compare
Today's Range
$77.85
$79.71
50-Day Range
$78.35
$86.17
52-Week Range
$75.36
$142.62
Volume5,402 shs
Average Volume145,528 shs
Market Capitalization$1.30 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.11

Madrigal Pharmaceuticals (NASDAQ:MDGL) SEC Filings

DateFilerForm TypeView
08/05/2021
7:31 AM
Madrigal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/05/2021
5:51 AM
Madrigal Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/04/2021
8:46 PM
Madrigal Pharmaceuticals (Issuer)
Waltermire Robert E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/04/2021
8:36 PM
Madrigal Pharmaceuticals (Issuer)
Waltermire Robert E. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/09/2021
11:27 AM
Capital Research Global Investors (Filed by)
Madrigal Pharmaceuticals (Subject)
Form SC 13G/A
06/29/2021
3:19 PM
Madrigal Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
06/21/2021
7:03 AM
Daly James M (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2021
7:03 AM
CRAVES FRED B (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2021
7:02 AM
Madrigal Pharmaceuticals (Issuer)
MILLIGAN DAVID V (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2021
7:02 AM
BATE KENNETH (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2021
7:02 AM
Levy Richard S (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2021
7:00 AM
Gollust Keith R (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/01/2021
7:01 AM
Madrigal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/01/2021
6:31 AM
Madrigal Pharmaceuticals (Filer)
Form 424B5
06/01/2021
6:00 AM
Madrigal Pharmaceuticals (Filer)
Form S-3ASR
05/19/2021
2:40 PM
Howarth Alex G. (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2021
2:39 PM
Howarth Alex G. (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
05/18/2021
7:30 AM
Madrigal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2021
7:31 AM
Madrigal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2021
5:10 AM
Madrigal Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
02/25/2021
10:05 AM
Madrigal Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/25/2021
7:58 AM
Madrigal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/23/2021
12:35 PM
FRIEDMAN PAUL A (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2021
12:32 PM
Madrigal Pharmaceuticals (Issuer)
Schneebaum Marc R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2021
12:31 PM
Madrigal Pharmaceuticals (Issuer)
Sukhija Remy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2021
12:29 PM
Lynch Brian Joseph (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2021
12:28 PM
Madrigal Pharmaceuticals (Issuer)
Taub Rebecca (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2021
7:06 AM
Avoro Capital Advisors LLC (Filed by)
Madrigal Pharmaceuticals (Subject)
Form SC 13G
02/11/2021
2:50 PM
CRAVES FRED B (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 5
Annual statement of changes in beneficial ownership of securities  
02/04/2021
10:31 AM
Madrigal Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
12/01/2020
8:36 PM
BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP (Reporting)
Bay City Capital Fund IV, L.P. (Reporting)
BAY CITY CAPITAL LLC (Reporting)
Bay City Capital Management IV LLC (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2020
8:52 AM
Madrigal Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
11/05/2020
8:39 AM
Madrigal Pharmaceuticals (Filer)
Form 424B5
11/05/2020
8:20 AM
Madrigal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/05/2020
7:52 AM
Madrigal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/05/2020
5:06 AM
Madrigal Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
09/04/2020
8:16 PM
BAY CITY CAPITAL LLC (Filed by)
Madrigal Pharmaceuticals (Subject)
Form SC 13D/A
09/04/2020
8:09 PM
BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP (Reporting)
Bay City Capital Fund IV, L.P. (Reporting)
BAY CITY CAPITAL LLC (Reporting)
Bay City Capital Management IV LLC (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2020
8:06 PM
CRAVES FRED B (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2020
6:40 PM
BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP (Reporting)
Bay City Capital Fund IV, L.P. (Reporting)
BAY CITY CAPITAL LLC (Reporting)
Bay City Capital Management IV LLC (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2020
6:40 PM
CRAVES FRED B (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/10/2020
6:07 PM
Lynch Brian Joseph (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2020
7:50 AM
Madrigal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2020
5:06 AM
Madrigal Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/18/2020
7:38 AM
Madrigal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/18/2020
6:53 AM
Daly James M (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2020
6:49 AM
Gollust Keith R (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2020
6:46 AM
BATE KENNETH (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2020
6:43 AM
Madrigal Pharmaceuticals (Issuer)
MILLIGAN DAVID V (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2020
6:41 AM
Levy Richard S (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2020
6:39 AM
CRAVES FRED B (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/01/2020
4:19 PM
BAY CITY CAPITAL LLC (Filed by)
Madrigal Pharmaceuticals (Subject)
Form SC 13D/A
05/29/2020
3:51 PM
CRAVES FRED B (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2020
3:51 PM
BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP (Reporting)
Bay City Capital Fund IV, L.P. (Reporting)
BAY CITY CAPITAL LLC (Reporting)
Bay City Capital Management IV LLC (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2020
5:03 AM
Madrigal Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/29/2020
4:15 PM
Madrigal Pharmaceuticals (Filer)
Form DEF 14A
04/02/2020
6:29 PM
Madrigal Pharmaceuticals (Issuer)
Sukhija Remy (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/26/2020
5:06 PM
Madrigal Pharmaceuticals (Issuer)
MILLIGAN DAVID V (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2020
4:41 PM
Madrigal Pharmaceuticals (Issuer)
MILLIGAN DAVID V (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2020
7:50 AM
Madrigal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/26/2020
5:15 AM
Madrigal Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/11/2020
3:44 PM
Madrigal Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G
01/28/2020
8:46 AM
Madrigal Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G
12/13/2019
4:14 PM
BAY CITY CAPITAL LLC (Filed by)
Madrigal Pharmaceuticals (Subject)
Form SC 13D/A
12/13/2019
1:18 PM
BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP (Reporting)
Bay City Capital Fund IV, L.P. (Reporting)
BAY CITY CAPITAL LLC (Reporting)
Bay City Capital Management IV LLC (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2019
1:08 PM
CRAVES FRED B (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2019
12:41 PM
CRAVES FRED B (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4/A
12/12/2019
4:31 PM
Madrigal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/12/2019
4:27 PM
Madrigal Pharmaceuticals (Filer)
Form 424B7
12/10/2019
3:37 PM
Madrigal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2019
7:31 AM
Madrigal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2019
5:03 AM
Madrigal Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/17/2019
2:46 PM
Madrigal Pharmaceuticals (Subject)
Taub Rebecca (Filed by)
Form SC 13D/A
10/17/2019
2:46 PM
FRIEDMAN PAUL A (Filed by)
Madrigal Pharmaceuticals (Subject)
Form SC 13D/A
10/17/2019
2:45 PM
BAY CITY CAPITAL LLC (Filed by)
Madrigal Pharmaceuticals (Subject)
Form SC 13D/A
08/07/2019
8:10 AM
Madrigal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2019
5:03 AM
Madrigal Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/11/2019
10:28 AM
Madrigal Pharmaceuticals (Issuer)
Taub Rebecca (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/11/2019
9:44 AM
Madrigal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/02/2019
11:40 AM
Madrigal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/01/2019
4:59 PM
Levy Richard S (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2019
4:58 PM
BATE KENNETH (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2019
4:55 PM
Daly James M (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2019
4:52 PM
Daly James M (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
07/01/2019
4:47 PM
CRAVES FRED B (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2019
4:39 PM
Gollust Keith R (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2019
4:13 PM
Madrigal Pharmaceuticals (Issuer)
MILLIGAN DAVID V (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2019
12:50 PM
Madrigal Pharmaceuticals (Filer)
Form DEFA14A
05/15/2019
12:46 PM
Madrigal Pharmaceuticals (Filer)
Form DEF 14A
05/08/2019
5:20 PM
Lynch Brian Joseph (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
05/08/2019
7:51 AM
Madrigal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2019
5:03 AM
Madrigal Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/30/2019
3:27 PM
Madrigal Pharmaceuticals (Filer)
Form 10-K/A
03/12/2019
10:52 AM
Madrigal Pharmaceuticals (Filer)
Form CT ORDER
03/11/2019
2:42 PM
Madrigal Pharmaceuticals (Issuer)
Taub Rebecca (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2019
2:42 PM
FRIEDMAN PAUL A (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2019
2:41 PM
Madrigal Pharmaceuticals (Issuer)
Schneebaum Marc R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2019
7:51 AM
Madrigal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/27/2019
5:03 AM
Madrigal Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/13/2019
3:29 PM
BAKER BROS. ADVISORS LP (Filed by)
Madrigal Pharmaceuticals (Subject)
Form SC 13G
This page was last updated on 10/25/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.